Abstract:Human papillomavirus-associated head and neck squamous cell carcinoma (HPV+ HNSCC) is one of the fastest-rising cancers in the US. While HPV+ HNSCC patients exhibit better responses to chemoradiation compared to HPV- HNSCC patients, a subset of HPV+ patients do not respond as well and develop recurrent/refractory disease. In this study, we investigated the potential role of HPV E5 in promoting resistance to conventional chemo- and radiotherapy, and the underlying molecular mechanisms. HPV E5 is a small hydrophobic viral oncoprotein with multiple functions including regulation of tumor cell differentiation and apoptosis, modulation of H+ ATPase responsible for acidification of late endosomes, and immune modulation. To test the impact of HPV E5 on therapeutic resistance, we generated HNSCC cell lines and normal keratinocytes expressing HPV16 E5. Upon treatment with radiation (2Gy, 4Gy, 8Gy) and/or cisplatin, HNSCC cells and keratinocytes expressing HPV 16 E5 had increased cell viability, decreased apoptosis, and increased colony-forming capacity compared to empty vector (EV) control lines. Specifically, treatment with 4Gy radiation, 4μM cisplatin, or the combination led to a ~2-fold decrease in % of apoptotic cells in HPV16 E5-expressing HNSCC cells compared to EV and HPV16 E6/E7 HNSCC cells (p <0.05). Examination of DNA damage response and repair pathways indicated that while HPV16 E5 HNSCC cells initially had increased phosphorylation of H2AX 6 hours post treatment, at 24 hours post treatment H2AX phosphorylation in HPV16 E5 cells was significantly decreased compared to EV or HPV16 E6/E7 HNSCC cells. These findings indicate increased DNA repair capacity of HPV16 E5 HNSCC cells. To identify mechanisms underlying this phenotype, we performed RNA-seq and observed enhanced signaling pathways associated with epithelial development and increased expression of stem cell markers in HPV16 E5 HNSCC cells compared to EV control lines. Functionally, we observed a ~2.5-fold increase in sphere-forming capacity and increased expression of markers associated with stem cell phenotype in HPV16 E5 HNSCC cells compared to EV and HPV E6/E7 HNSCC cells. To determine whether these findings translated clinically, 18 HPV+ HNSCC patients from the GSE74927 dataset were grouped according to median expression level of HPV E5 (High vs Low). In support of our hypothesis, HPV E5-High patients exhibited enrichment of pathways associated with extrinsic apoptotic signaling, pluripotency of stem cells, and positive regulation of DNA repair. Taken together these results identify HPV E5 as a potential mediator of resistance to conventional radiation and chemotherapy in HNSCC and suggest that patient tumors expressing HPV E5 may have increased DNA repair capacity and cell survival after cytotoxic therapies. Citation Format: Souvick Roy, Sayuri Miyauchi, Riley Jones, Sangwoo Kim, Andrew B. Sharabi. Resistance to conventional chemo and radiotherapy associated with increased DNA repair and stem cell-like phenotype in head and neck squamous cell carcinoma expressing HPV E5 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2875.

Human papillomavirus 16 E2 blocks cellular senescence in response to activation of the DNA damage response.

Effects of Human Papillomavirus Type 16 E7 Protein on the Growth of Cervical Carcinoma Cells and Immuno-Escape Through the TGF-β1 Signaling Pathway

Influence of Human Papillomavirus E7 Oncoprotein on Maturation and Function of Plasmacytoid Dendritic Cells in Vitro

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

A Critical Role for p53 during the HPV16 Life Cycle

A human papillomavirus 16 E2-TopBP1 dependent SIRT1-p300 acetylation switch regulates mitotic viral and human protein levels and activates the DNA damage response

Abstract A003: HPV infection causes dependence on alternative DNA damage response pathways providing cancer specific targets for radiosensitization

The Human Papillomavirus Type 16 E5 Oncoprotein Synergizes with EGF-receptor Signaling to Enhance Cell Cycle Progression and the Down-Regulation of P27(kip1).

Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP

Activation of Cdc2 Contributes to Apoptosis in HPV E6 Expressing Human Keratinocytes in Response to Therapeutic Agents

Human Papillomavirus-16 E6 Activates the Pentose Phosphate Pathway to Promote Cervical Cancer Cell Proliferation by Inhibiting G6PD Lactylation

In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line.

Abstract 2875: Resistance to conventional chemo and radiotherapy associated with increased DNA repair and stem cell-like phenotype in head and neck squamous cell carcinoma expressing HPV E5

CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells

Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells

Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells

A human papillomavirus 16 E2-TopBP1 dependent SIRT1-p300 acetylation switch regulates mitotic viral and human protein levels

The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo

The effects of HPV 16 E6 on active release of high mobility group box-Bl and the invasion ability of cervical cancer cells

Human Papilloma Virus Type16 E6 Deregulates CHK1 and Sensitizes Human Fibroblasts to Environmental Carcinogens Independently of Its Effect on P53

Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells